TrialJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2024

Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study.

Sławomir Jeka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.